BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30991432)

  • 1. Clinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil.
    Yoshida A; Tavares BVG; Sarian LO; Andrade LALÂ; Derchain SF
    Rev Bras Ginecol Obstet; 2019 Mar; 41(3):176-182. PubMed ID: 30991432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland.
    Kipp B; Vidal A; Lenick D; Christmann-Schmid C
    J Ovarian Res; 2023 Jan; 16(1):20. PubMed ID: 36691070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study.
    Ouldamer L; Bendifallah S; Nikpayam M; Body G; Fritel X; Uzan C; Morice P; Daraï E; Ballester M
    BJOG; 2017 May; 124(6):937-944. PubMed ID: 28122418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
    Koensgen D; Weiss M; Assmann K; Brucker SY; Wallwiener D; Stope MB; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1539-1545. PubMed ID: 29491083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
    Dewilde K; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):65-69. PubMed ID: 28689208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
    Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
    Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
    Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
    May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
    Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in borderline ovarian tumors.
    Seong SJ; Kim DH; Kim MK; Song T
    J Gynecol Oncol; 2015 Oct; 26(4):343-9. PubMed ID: 26404125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on 68 cases with struma ovarii].
    Wang Y; Pan L; Huang H; Shen K; Wu M; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):451-4. PubMed ID: 25169639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of borderline ovarian tumors: single center experience of 183 cases.
    Gungor T; Cetinkaya N; Yalcin H; Ozdal B; Ozgu E; Baser E; Uygur D; Caglar M; Sirvan L; Erkaya S
    Arch Gynecol Obstet; 2015 Jan; 291(1):123-30. PubMed ID: 25047273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.